相似文献
1
Hepatic methotrexate content and progression of hepatic fibrosis: preliminary findings.
Ann Rheum Dis. 1991 Jul;50(7):477-80. doi: 10.1136/ard.50.7.477.
2
Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
Ann Rheum Dis. 1991 Jul;50(7):471-6. doi: 10.1136/ard.50.7.471.
3
Analysis of methotrexate polyglutamate derivatives in vivo.
Methods Enzymol. 1986;122:339-46. doi: 10.1016/0076-6879(86)22191-6.
4
Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
Arthritis Rheum. 2009 Aug;60(8):2248-56. doi: 10.1002/art.24653.
5
Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis.
Arthritis Rheumatol. 2014 Aug;66(8):2026-36. doi: 10.1002/art.38652.
6
Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis.
Ann Rheum Dis. 2015 Feb;74(2):408-14. doi: 10.1136/annrheumdis-2013-203725. Epub 2013 Dec 2.
7
Measuring methotrexate polyglutamates.
Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S24-6. Epub 2010 Oct 28.
8
The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis.
Arthritis Rheum. 1993 Dec;36(12):1697-701. doi: 10.1002/art.1780361208.
9
A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.
Clin Exp Rheumatol. 2012 Mar-Apr;30(2):156-63. Epub 2012 Apr 13.
10
Hepatic fibrosis in rheumatoid arthritis patients treated with methotrexate: application of a new semi-quantitative scoring system.
Rheumatology (Oxford). 2000 Jan;39(1):50-4. doi: 10.1093/rheumatology/39.1.50.
引用本文的文献
1
A clinical and economic review of disease-modifying antirheumatic drugs.
Pharmacoeconomics. 2001;19(7):715-28. doi: 10.2165/00019053-200119070-00002.
2
Methotrexate in rheumatoid arthritis. An update.
Drugs. 1994 Jan;47(1):25-50. doi: 10.2165/00003495-199447010-00003.
3
Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.
Ann Rheum Dis. 1991 Jul;50(7):471-6. doi: 10.1136/ard.50.7.471.
本文引用的文献
1
Methotrexate guidelines--revised.
J Am Acad Dermatol. 1982 Feb;6(2):145-55. doi: 10.1016/s0190-9622(82)80064-9.
2
Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug.
Br J Haematol. 1981 Nov;49(3):355-60. doi: 10.1111/j.1365-2141.1981.tb07237.x.
3
Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.
Br Med J. 1972 Mar 11;1(5801):654-6. doi: 10.1136/bmj.1.5801.654.
4
Liver injury associated with methotrexate therapy for psoriasis.
Mayo Clin Proc. 1973 Nov;48(11):787-92.
5
Changes in liver histology during methotrexate therapy of psoriasis correlated to the concentration of methotrexate and folate in erythrocytes.
Acta Pharmacol Toxicol (Copenh). 1985 Apr;56(4):321-6. doi: 10.1111/j.1600-0773.1985.tb01297.x.
6
A microcomputer system for video image analysis and diagnostic microdensitometry.
Anal Quant Cytol Histol. 1986 Sep;8(3):201-9.
7
Methotrexate pharmacokinetics in psoriatic patients developing hepatic fibrosis.
Arch Dermatol. 1986 Jun;122(6):666-9.
8
Hepatotoxicity of methotrexate in rheumatic diseases.
Med Toxicol Adverse Drug Exp. 1988 May-Jun;3(3):197-208. doi: 10.1007/BF03259882.
9
Methotrexate in rheumatoid arthritis.
Arthritis Rheum. 1988 Mar;31(3):305-14. doi: 10.1002/art.1780310301.
10
Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples.
Arthritis Rheum. 1989 Feb;32(2):121-7. doi: 10.1002/anr.1780320202.
Zotero 插件